BeatCheck

At BeatCheck, we are revolutionizing congenital heart disease (CHD) detection and intervention by bridging the gap between diagnosis and treatment. Our AI-powered companion diagnostic device enhances Pulse Oximetry Screening with unmatched accuracy, eliminating the need for specialized training while providing personalized treatment recommendations. By seamlessly integrating early detection with AI-driven intervention guidance, we empower hospitals with cost-effective, life-saving technology that not only identifies CHDs but also optimizes patient outcomes. We aim to develop innovative intervention solutions, ensuring that every newborn receives the right treatment at the right time. At BeatCheck, we're not just diagnosing—we're redefining the future of pediatric cardiac care. BeatCheck develops the BeatScan NeoPulse, an AI-enhanced portable pulse oximeter system that enables hospitals and birthing centers to screen newborns for critical congenital heart defects (cCHD) with greater speed and diagnostic accuracy. Beyond healthcare, BeatCheck automates solutions across industrial sectors using 3D modeling (CAD), PLCs, electrical systems, 3D printing, design and prototyping with diverse materials, soldering, welding, data analysis, and advanced simulations (CFD, FEA), bringing research-driven innovation to life.

• Employees 1